Faria Bernardo, Rodrigues Anabela
Nephrology and Dialysis Unit, Hospital São Teotónio, Viseu, Portugal.
Scand J Urol Nephrol. 2011 Dec;45(6):444-51. doi: 10.3109/00365599.2011.592857. Epub 2011 Jun 27.
Transplant recipient patients performing dialysis represent a growing population in the integrated model of renal replacement therapy. This includes both patients with kidney allograft loss and non-renal organ transplant recipients requiring dialysis. Although a number of possible advantages of peritoneal dialysis over haemodialysis could hypothetically favour its choice when starting dialysis, peritoneal dialysis penetration is relatively residual in this population. Questions about its safety and adequacy in these patients can explain this fact. The purpose of this review is to address unfounded fears and document evidence that peritoneal dialysis should be considered a viable and safe choice in patients returning to dialysis. Specific issues that still need further investigation are also discussed.
在肾脏替代治疗的综合模式中,进行透析的移植受者患者群体在不断扩大。这包括肾移植失败的患者以及需要透析的非肾器官移植受者。尽管理论上腹膜透析相对于血液透析有一些可能的优势,在开始透析时可能更倾向于选择腹膜透析,但在这一群体中腹膜透析的普及率相对较低。关于其在这些患者中的安全性和充分性的问题可以解释这一现象。本综述的目的是消除无端的担忧,并记录证据表明腹膜透析应被视为重新开始透析的患者的一种可行且安全的选择。还讨论了仍需进一步研究的具体问题。